← Evidence map

ArticleJournal of translational medicine2019

The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients.

M G Dal Bello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

106 papers cite itlatest 60 shown

2019
…
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 30849967